IGCS shares knowledge to establish high standards and raise public awareness for detection and treatment of women’s cancer. Learn More 

EducateIGCS shares knowledge...

Alliances with organizations whose goals align with those of the IGCS strengthen our message and broaden the reach of our mission. Learn More 

CollaborateAlliances with organizations...

To enhance the care of women with gynecologic cancer worldwide through education, training, and public awareness. Learn More 

Our MissionTo enhance the care of women...

IGCS membership includes experts in women’s cancer care from around the world. Learn More 

LeadIGCS membership includes...

Our members are valuable resources that facilitate professional connections on a global scale to share knowledge to improve the lives of women with cancer. Learn More 

UniteOur members are valuable...

IGCS members advocate on behalf of patients to empower and protect their interests and strive to provide patients access to available resources. Learn More 

AdvocateIGCS members advocate on...

Meet our members working hard around the globe in the fight against gynecologic cancers. Learn More 

Member SpotlightMeet our members...

Featured Announcements

Gynecologic Oncology News & Updates
Jan 13, 2017

A compilation of news articles in the field of gynecologic oncology and recent scientific studies ...

read more

Website Features
Jan 06, 2017

Dear IGCS Member, Happy new year! Hopefully by now, you have had a chance to explore the new IGCS we...

read more

Top IJGC Articles of 2016
Jan 04, 2017

As the new year begins, let’s take a look back at the top viewed articles of the Internationa...

read more

Cervical Health Awareness Month
Jan 04, 2017

January is Cervical Health Awareness Month in the USA. The International Gynecologic Cancer Society ...

read more

President’s Perspective
Dec 27, 2016

Dear Colleagues, I am extremely honored to have been elected President of IGCS and look forward to w...

read more

Read the Current Issue of IJGC
Dec 22, 2016

IJGC is the scientific publication for topics relevant to detection, prevention, diagnosis, and trea...

read more


We strive for global representation, reflecting the diverse cultural, economic and geographic impact of gynecologic cancer. IGCS is the only organization with diverse membership and leadership.

Our Patients

Are women affected by cancers of the reproductive system..

read more

Gynecologic Cancers

Endometrial (Uterine)

read more

New Cancer Cases

According to comprehensive 2012 global cancer statistics from the International Agency for Research on Cancer, gynecologic cancer accounted for 16.3% of 6.6 million estimated new cancer cases in women.

read more


  • Gynecologic Oncologist
  • Surgical Oncologist
  • Medical Oncologist
  • Pathologist
  • Radiation Oncologist
  • Allied Health
  • Residents
  • Fellows


North America


Central America & Carribean


South America






Middle East





member spotlight

Walter GotliebProfessor and Director of Surgical Oncology, McGill University - Jewish General Hospital

IGCS member since 1992.

I decided to pursue a career in gynecologic oncology because it is a specialty with a genuinely caring prolonged intimate human interaction, extending over multiple facets of state of the art medicine.

My day to day activities consist of a blend of providing care and teaching in the clinic, the ward and the OR, mixed with bench to bedside translational and clinical research, influencing and innovating the practice of our specialty in the present while placing the seeds for the future.

Lynette DennyProfessor, University of Cape Town/Groote Schuur Hospital

IGCS member since 1998.

I decided to pursue a career in gynecologic oncology because I was drawn to the inequity of access and quality of care of women with gynaecological cancer between low, middle and high income countries and to look for pragmatic and realistic ways if preventing cervical cancer among women in developing countries.

I run large community based awareness, early detection and prevention programmes, I teach at both under and postgraduate level, supervise masters and PhD students and contribute to providing a large mulitidisciplinary clinical service to women with gynaecological cancer.

Roberto AngioliCampus Bio Medico University of Rome Professional Title: Professor and Director of Gynecology Department

IGCS Member since 1997.

My devotion to gynecologic oncology is a lifelong commitment. I chose to pursue a career in this specialty because it allows for intimate human interaction, and is a perfect link between medical and surgical aspects.

I would like to focus on providing young professionals with more opportunities for education and training and I intend to give a strong emphasis on the holistic care and quality of life of women with gynecological cancer, giving greater attention to spiritual, psycho-social and sexual health and other consequences of female cancer. I would also  like eliminate barriers between developed and developing countries and minimizing large therapeutic gaps so that all women could receive optimal treatment, regardless of their origin or their social status.

Robert SoslowMemorial Sloan-Kettering Cancer Center/Professor of Pathology and Laboratory Medicine (Weill Cornell Medicine) and Attending Pathologist (Memorial Hospital)

IGCS member since 2015.

I decided to pursue a career in gynecologic oncology because there was a need for a diagnostic gynecologic pathology specialist at Memorial Sloan Kettering Cancer Center.  Having had rigorous training in that area during my residency, I decided to apply for that position.  Superb collaborations with gynecologic and medical oncologists at our Center convinced me I had made the right decision.

I spend about 1/3 of my time in diagnostic gynecologic pathology, working one-on-one with pathology trainees and discussing results with our clinical colleagues. Most of our work derives from patients at our Center, but we also handle a good number of diagnostic second opinions.  Another 1/3 of my time is spent doing collaborative gynecologic oncologic research, ranging from simple, retrospective and observational studies that bridge clinical medicine and pathology to projects involving the use of sophisticated molecular technologies.  The remainder of my time is spent in departmental administration.  Currently, our research focuses on risk stratification for patients with endometrial cancer, clinicopathological classification of endocervical adenocarcinoma and uterine mesenchymal tumors, the Fallopian tube’s role in ovarian carcinogenesis and genotype-phenotype-clinical correlations of heritable gynecologic cancer syndromes.


in the fight against women’s cancer worldwide

Apply for a Membership